MAPT and Alzheimer disease: We and others demonstrated that [18F]-Flortaucipir binds with strong affinity to tau aggregates in AD with a binding pattern that closely matches the accumulation and spreading of tau lesions through increasing Braak stages in parallel with the progression and severity of clinical symptoms of the disease [30, 32, 33, 37, 44].